RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines-Reference-Cited by-同舟云学术

RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines

Published:2021-12-01 Issue:12 Volume:44 Page:1843-1850
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Katayama Kazuhiro¹,Nishihata Ayane²

Affiliation:

1. Laboratory of Molecular Targeted Therapeutics, School of Pharmacy, Nihon University

2. Division of Chemotherapy, Faculty of Pharmacy, Keio University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/12/44_b21-00531/_pdf

Reference39 articles.

1. 1) NCI. NIH. “Cancer stat facts: leukemia — acute myeloid leukemia (AML).”: ‹https://seer.cancer.gov/statfacts/html/amyl.html›, accessed 17 February, 2021.

2. 2) Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. “SEER Cancer Statistics Review (CSR) 1975–2015.” National Cancer Institute. Bethesda, MD.: ‹https://seer.cancer.gov/csr/1975_2015/›, accessed 2 March, 2021.

3. 3) Saygin C, Carraway HE. Emerging therapies for acute myeloid leukemia. J. Hematol. Oncol., 10, 93 (2017).

4. 4) Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, Yabe H, Nakayama H, Kudo K, Kobayashi R, Hamamoto K, Imaizumi M, Morimoto A, Tsuchiya S, Hanada R. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese childhood AML cooperative study group. J. Clin. Oncol., 27, 4007–4013 (2009).

5. 5) Miyamoto K, Minami Y. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01. Int. J. Clin. Oncol., 24, 893–898 (2019).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges;European Journal of Medicinal Chemistry;2023-05

2. BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis;Cancers;2023-03-28

3. Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines;Cellular Oncology;2022-08-29